Benchmark Co. Keeps Their Hold Rating on Cross Country Healthcare (CCRN)
Benchmark Co. analyst Bill Sutherland maintained a Hold rating on Cross Country Healthcare today. The company’s shares closed yesterday at $13.60.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Sutherland is an analyst with an average return of -3.1% and a 41.20% success rate. Sutherland covers the Healthcare sector, focusing on stocks such as Select Medical, Clinigence Holdings, and Cross Country Healthcare.
Cross Country Healthcare has an analyst consensus of Hold, with a price target consensus of $16.74.
Based on Cross Country Healthcare’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $274.07 million and a GAAP net loss of $6.66 million. In comparison, last year the company earned a revenue of $339.77 million and had a GAAP net loss of $16.05 million
Read More on CCRN:
Disclaimer & DisclosureReport an Issue
- Cross Country Healthcare Extends Merger Agreement Deadline
- Cross Country Healthcare Reports Q2 2025 Financial Results
- Cautious Hold Rating for Cross Country Healthcare Amid Revenue Decline and Acquisition Uncertainty
- Cross Country Healthcare reports Q2 adjusted EPS (1c), consensus 6c
- Is CCRN a Buy, Before Earnings?
